Re: Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration

J Urol. 1999 Jul;162(1):170. doi: 10.1097/00005392-199907000-00057.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Drug Administration Schedule
  • Goserelin / administration & dosage*
  • Goserelin / analogs & derivatives*
  • Humans
  • Leuprolide / administration & dosage*
  • Male
  • Neoadjuvant Therapy
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / drug therapy*
  • Testosterone / blood*
  • Time Factors

Substances

  • Antineoplastic Agents, Hormonal
  • Goserelin
  • Testosterone
  • Leuprolide